The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023
Drug & Device Law
DECEMBER 29, 2023
2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. United States Department of Health and Human Services , 58 F.4th Instead, Zofran turned mainly on animal studies – three Japanese studies that were not “newly acquired information” that could avoid preemption. Monsanto Co. , 4th 1261 (11th Cir. 4th 696 (3d.
105 
Let's personalize your content